# Core & Main, Inc.: financial statements, quarterly

CNM · NYSE · CIK 1856525 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/cnm.md) · [Financials](/companies/cnm/financials.md) · [Filings](/companies/cnm/filings.md) · [Insiders](/companies/cnm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cnm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-29) | Q4 FY2023 (2024-01-28) | Q1 FY2024 (2024-04-28) | Q2 FY2024 (2024-07-28) | Q3 FY2024 (2024-10-27) | Q4 FY2024 (2025-02-02) | Q1 FY2025 (2025-05-04) | Q2 FY2025 (2025-08-03) | Q3 FY2025 (2025-11-02) | Q4 FY2025 (2026-02-01) | Q1 FY2026 (2026-05-03) | Q2 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,827](/filings/0001856525-24-000118.md) | [1,440 d](/filings/0001856525-26-000031.md) | [1,741](/filings/0001856525-25-000116.md) | [1,964](/filings/0001856525-25-000173.md) | [2,038](/filings/0001856525-25-000179.md) | [1,698 d](/filings/0001856525-26-000031.md) | [1,911](/filings/0001856525-26-000054.md) | [2,093](/filings/0001856525-26-000092.md) | [2,062](/filings/0001856525-25-000179.md) | [1,581 d](/filings/0001856525-26-000031.md) | [1,910](/filings/0001856525-26-000054.md) | [2,145](/filings/0001856525-26-000092.md) |
| Cost of revenue | $m | [1,333](/filings/0001856525-24-000118.md) | [1,056 d](/filings/0001856525-26-000031.md) | [1,273](/filings/0001856525-25-000116.md) | [1,446](/filings/0001856525-25-000173.md) | [1,495](/filings/0001856525-25-000179.md) | [1,247 d](/filings/0001856525-26-000031.md) | [1,401](/filings/0001856525-26-000054.md) | [1,533](/filings/0001856525-26-000092.md) | [1,501](/filings/0001856525-25-000179.md) | [1,153 d](/filings/0001856525-26-000031.md) | [1,390](/filings/0001856525-26-000054.md) | [1,572](/filings/0001856525-26-000092.md) |
| Gross profit | $m | [494](/filings/0001856525-24-000118.md) | [384 d](/filings/0001856525-26-000031.md) | [468](/filings/0001856525-25-000116.md) | [518](/filings/0001856525-25-000173.md) | [543](/filings/0001856525-25-000179.md) | [451 d](/filings/0001856525-26-000031.md) | [510](/filings/0001856525-26-000054.md) | [560](/filings/0001856525-26-000092.md) | [561](/filings/0001856525-25-000179.md) | [428 d](/filings/0001856525-26-000031.md) | [520](/filings/0001856525-26-000054.md) | [573](/filings/0001856525-26-000092.md) |
| Selling, general and administrative | $m | [240](/filings/0001856525-24-000118.md) | [230 d](/filings/0001856525-26-000031.md) | [257](/filings/0001856525-25-000116.md) | [268](/filings/0001856525-25-000173.md) | [274](/filings/0001856525-25-000179.md) | [279 d](/filings/0001856525-26-000031.md) | [293](/filings/0001856525-26-000054.md) | [302](/filings/0001856525-26-000092.md) | [295](/filings/0001856525-25-000179.md) | [264 d](/filings/0001856525-26-000031.md) | [299](/filings/0001856525-26-000054.md) | [301](/filings/0001856525-26-000092.md) |
| Operating income | $m | [217](/filings/0001856525-24-000118.md) | [116 d](/filings/0001856525-26-000031.md) | [168](/filings/0001856525-25-000116.md) | [204](/filings/0001856525-25-000173.md) | [223](/filings/0001856525-25-000179.md) | [124 d](/filings/0001856525-26-000031.md) | [171](/filings/0001856525-26-000054.md) | [213](/filings/0001856525-26-000092.md) | [220](/filings/0001856525-25-000179.md) | [118 d](/filings/0001856525-26-000031.md) | [177](/filings/0001856525-26-000054.md) | [227](/filings/0001856525-26-000092.md) |
| Interest expense | $m | [20.0](/filings/0001856525-24-000118.md) | [22.0 d](/filings/0001856525-24-000036.md) | [34.0](/filings/0001856525-25-000116.md) | [36.0](/filings/0001856525-25-000173.md) | [36.0](/filings/0001856525-25-000179.md) | [36.0 d](/filings/0001856525-26-000031.md) | [30.0](/filings/0001856525-26-000054.md) | [31.0](/filings/0001856525-26-000092.md) | [30.0](/filings/0001856525-25-000179.md) | [29.0 d](/filings/0001856525-26-000031.md) | [27.0](/filings/0001856525-26-000054.md) | [32.0](/filings/0001856525-26-000092.md) |
| Income tax | $m | [39.0](/filings/0001856525-24-000118.md) | [18.0 d](/filings/0001856525-26-000031.md) | [33.0](/filings/0001856525-25-000116.md) | [42.0](/filings/0001856525-25-000173.md) | [47.0](/filings/0001856525-25-000179.md) | [21.0 d](/filings/0001856525-26-000031.md) | [36.0](/filings/0001856525-26-000054.md) | [41.0](/filings/0001856525-26-000092.md) | [47.0](/filings/0001856525-25-000179.md) | [21.0 d](/filings/0001856525-26-000031.md) | [37.0](/filings/0001856525-26-000054.md) | [43.0](/filings/0001856525-26-000092.md) |
| Net income | $m | [112](/filings/0001856525-24-000118.md) | [63.0 d](/filings/0001856525-26-000031.md) | [95.0](/filings/0001856525-25-000116.md) | [119](/filings/0001856525-25-000173.md) | [133](/filings/0001856525-25-000179.md) | [64.0 d](/filings/0001856525-26-000031.md) | [100](/filings/0001856525-26-000054.md) | [134](/filings/0001856525-26-000092.md) | [137](/filings/0001856525-25-000179.md) | [70.0 d](/filings/0001856525-26-000031.md) | [108](/filings/0001856525-26-000054.md) | [144](/filings/0001856525-26-000092.md) |
| Diluted EPS | $ per share | [0.65](/filings/0001856525-24-000118.md) | not reported | [0.49](/filings/0001856525-25-000116.md) | [0.61](/filings/0001856525-25-000173.md) | [0.69](/filings/0001856525-25-000179.md) | not reported | [0.52](/filings/0001856525-26-000054.md) | [0.70](/filings/0001856525-26-000092.md) | [0.72](/filings/0001856525-25-000179.md) | not reported | [0.57](/filings/0001856525-26-000054.md) | [0.77](/filings/0001856525-26-000092.md) |
| Basic EPS | $ per share | [0.65](/filings/0001856525-24-000118.md) | not reported | [0.49](/filings/0001856525-25-000116.md) | [0.62](/filings/0001856525-25-000173.md) | [0.69](/filings/0001856525-25-000179.md) | not reported | [0.53](/filings/0001856525-26-000054.md) | [0.71](/filings/0001856525-26-000092.md) | [0.72](/filings/0001856525-25-000179.md) | not reported | [0.57](/filings/0001856525-26-000054.md) | [0.77](/filings/0001856525-26-000092.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-29) | FY2023 (2024-01-28) | Q1 FY2024 (2024-04-28) | Q2 FY2024 (2024-07-28) | Q3 FY2024 (2024-10-27) | FY2024 (2025-02-02) | Q1 FY2025 (2025-05-04) | Q2 FY2025 (2025-08-03) | Q3 FY2025 (2025-11-02) | FY2025 (2026-02-01) | Q1 FY2026 (2026-05-03) | Q2 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [101](/filings/0001856525-23-000049.md) | [1.0](/filings/0001856525-25-000081.md) | [30.0](/filings/0001856525-24-000072.md) | [13.0](/filings/0001856525-24-000111.md) | [10.0](/filings/0001856525-24-000118.md) | [8.0](/filings/0001856525-26-000031.md) | [8.0](/filings/0001856525-25-000116.md) | [25.0](/filings/0001856525-25-000173.md) | [89.0](/filings/0001856525-25-000179.md) | [220](/filings/0001856525-26-000092.md) | [150](/filings/0001856525-26-000054.md) | [312](/filings/0001856525-26-000092.md) |
| Current assets | $m | [2,171](/filings/0001856525-23-000049.md) | [1,773](/filings/0001856525-25-000081.md) | [2,223](/filings/0001856525-24-000072.md) | [2,318](/filings/0001856525-24-000111.md) | [2,381](/filings/0001856525-24-000118.md) | [2,025](/filings/0001856525-26-000031.md) | [2,444](/filings/0001856525-25-000116.md) | [2,510](/filings/0001856525-25-000173.md) | [2,507](/filings/0001856525-25-000179.md) | [2,302](/filings/0001856525-26-000092.md) | [2,557](/filings/0001856525-26-000054.md) | [2,937](/filings/0001856525-26-000092.md) |
| Total assets | $m | [5,067](/filings/0001856525-23-000049.md) | [5,069](/filings/0001856525-25-000081.md) | [6,041](/filings/0001856525-24-000072.md) | [6,098](/filings/0001856525-24-000111.md) | [6,215](/filings/0001856525-24-000118.md) | [5,870](/filings/0001856525-26-000031.md) | [6,278](/filings/0001856525-25-000116.md) | [6,306](/filings/0001856525-25-000173.md) | [6,300](/filings/0001856525-25-000179.md) | [6,085](/filings/0001856525-26-000092.md) | [6,324](/filings/0001856525-26-000054.md) | [6,709](/filings/0001856525-26-000092.md) |
| Current liabilities | $m | [921](/filings/0001856525-23-000049.md) | [774](/filings/0001856525-25-000081.md) | [1,038](/filings/0001856525-24-000072.md) | [1,012](/filings/0001856525-24-000111.md) | [1,114](/filings/0001856525-24-000118.md) | [866](/filings/0001856525-26-000031.md) | [1,246](/filings/0001856525-25-000116.md) | [1,117](/filings/0001856525-25-000173.md) | [1,107](/filings/0001856525-25-000179.md) | [874](/filings/0001856525-26-000092.md) | [1,106](/filings/0001856525-26-000054.md) | [1,190](/filings/0001856525-26-000092.md) |
| Total liabilities | $m | [2,852](/filings/0001856525-23-000049.md) | [3,545](/filings/0001856525-25-000081.md) | [4,397](/filings/0001856525-24-000072.md) | [4,378](/filings/0001856525-24-000111.md) | [4,465](/filings/0001856525-24-000118.md) | [4,096](/filings/0001856525-26-000031.md) | [4,457](/filings/0001856525-25-000116.md) | [4,344](/filings/0001856525-25-000173.md) | [4,245](/filings/0001856525-25-000179.md) | [4,011](/filings/0001856525-26-000092.md) | [4,210](/filings/0001856525-26-000054.md) | [4,605](/filings/0001856525-26-000092.md) |
| Long-term debt | $m | [1,436](/filings/0001856525-23-000049.md) | [1,863](/filings/0001856525-25-000081.md) | [2,401](/filings/0001856525-24-000072.md) | [2,404](/filings/0001856525-24-000111.md) | [2,384](/filings/0001856525-24-000118.md) | [2,237](/filings/0001856525-26-000031.md) | [2,239](/filings/0001856525-25-000116.md) | [2,234](/filings/0001856525-25-000173.md) | [2,129](/filings/0001856525-25-000179.md) | [2,124](/filings/0001856525-26-000092.md) | [2,120](/filings/0001856525-26-000054.md) | [2,432](/filings/0001856525-26-000092.md) |
| Current portion of debt | $m | [15.0](/filings/0001856525-23-000049.md) | [15.0](/filings/0001856525-25-000081.md) | [23.0](/filings/0001856525-24-000072.md) | [23.0](/filings/0001856525-24-000111.md) | [23.0](/filings/0001856525-24-000118.md) | [24.0](/filings/0001856525-26-000031.md) | [24.0](/filings/0001856525-25-000116.md) | [24.0](/filings/0001856525-25-000173.md) | [24.0](/filings/0001856525-25-000179.md) | [24.0](/filings/0001856525-26-000092.md) | [24.0](/filings/0001856525-26-000054.md) | [17.0](/filings/0001856525-26-000092.md) |
| Shareholders' equity | $m | [1,769](/filings/0001856525-23-000049.md) | [1,451](/filings/0001856525-25-000081.md) | [1,570](/filings/0001856525-24-000072.md) | [1,644](/filings/0001856525-24-000111.md) | [1,671](/filings/0001856525-24-000118.md) | [1,698](/filings/0001856525-26-000031.md) | [1,744](/filings/0001856525-25-000116.md) | [1,886](/filings/0001856525-25-000173.md) | [1,977](/filings/0001856525-25-000179.md) | [1,997](/filings/0001856525-26-000092.md) | [2,040](/filings/0001856525-26-000054.md) | [2,031](/filings/0001856525-26-000092.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-29) | Q4 FY2023 (2024-01-28) | Q1 FY2024 (2024-04-28) | Q2 FY2024 (2024-07-28) | Q3 FY2024 (2024-10-27) | Q4 FY2024 (2025-02-02) | Q1 FY2025 (2025-05-04) | Q2 FY2025 (2025-08-03) | Q3 FY2025 (2025-11-02) | Q4 FY2025 (2026-02-01) | Q1 FY2026 (2026-05-03) | Q2 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [373 d](/filings/0001856525-24-000118.md) | [294 d](/filings/0001856525-26-000031.md) | [78.0](/filings/0001856525-25-000116.md) | [48.0 d](/filings/0001856525-25-000173.md) | [260 d](/filings/0001856525-25-000179.md) | [235 d](/filings/0001856525-26-000031.md) | [77.0](/filings/0001856525-26-000054.md) | [34.0 d](/filings/0001856525-26-000092.md) | [271 d](/filings/0001856525-25-000179.md) | [268 d](/filings/0001856525-26-000031.md) | [82.0](/filings/0001856525-26-000054.md) | [62.0 d](/filings/0001856525-26-000092.md) |
| Capital expenditure | $m | [19.0 d](/filings/0001856525-24-000118.md) | [5.0 d](/filings/0001856525-26-000031.md) | [7.0](/filings/0001856525-25-000116.md) | [9.0 d](/filings/0001856525-25-000173.md) | [8.0 d](/filings/0001856525-25-000179.md) | [11.0 d](/filings/0001856525-26-000031.md) | [13.0](/filings/0001856525-26-000054.md) | [10.0 d](/filings/0001856525-26-000092.md) | [8.0 d](/filings/0001856525-25-000179.md) | [15.0 d](/filings/0001856525-26-000031.md) | [14.0](/filings/0001856525-26-000054.md) | [18.0 d](/filings/0001856525-26-000092.md) |
| Share repurchases | $m | [145 d](/filings/0001856525-24-000118.md) | [726 d](/filings/0001856525-26-000031.md) | [0.0](/filings/0001856525-25-000116.md) | [21.0 d](/filings/0001856525-25-000173.md) | [100 d](/filings/0001856525-25-000179.md) | [55.0 d](/filings/0001856525-26-000031.md) | [39.0](/filings/0001856525-26-000054.md) | [8.0 d](/filings/0001856525-26-000092.md) | [50.0 d](/filings/0001856525-25-000179.md) | [58.0 d](/filings/0001856525-26-000031.md) | [88.0](/filings/0001856525-26-000054.md) | [169 d](/filings/0001856525-26-000092.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-30) | Q1 FY2023 (2023-04-30) | Q2 FY2023 (2023-07-30) | Q3 FY2023 (2023-10-29) | Q1 FY2024 (2024-04-28) | Q2 FY2024 (2024-07-28) | Q3 FY2024 (2024-10-27) | Q1 FY2025 (2025-05-04) | Q2 FY2025 (2025-08-03) | Q3 FY2025 (2025-11-02) | Q1 FY2026 (2026-05-03) | Q2 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [246](/filings/0001856525-23-000049.md) | [244](/filings/0001856525-24-000072.md) | [229](/filings/0001856525-24-000111.md) | [225](/filings/0001856525-24-000118.md) | [203](/filings/0001856525-25-000116.md) | [203](/filings/0001856525-25-000173.md) | [201](/filings/0001856525-25-000179.md) | [199](/filings/0001856525-26-000054.md) | [198](/filings/0001856525-26-000092.md) | [198](/filings/0001856525-25-000179.md) | [196](/filings/0001856525-26-000054.md) | [193](/filings/0001856525-26-000092.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.